Klinische studies
ClinicalTrials.gov
Hieronder vindt u alle open fase III studies omtrent kanker. Deze lijst is samengesteld door www.clinicaltrials.gov, een register van klinische studies wereldwijd. Deze studies kunnen zowel met privégeld als met overheidsgeld gesponsord zijn.
U kan in deze lijst zoeken door een kankertype in het Engels in te geven, een bepaald land te selecteren, te zoeken naar een trefwoord of door de NCT-code van de studie waarnaar u op zoek bent in te geven.
Bijvoorbeeld, als Duitse kankerpatiënte kan u borstkanker ingeven als kankertype en zoeken naar studies in Duitsland.
Binnen een studie die u hebt geselecteerd kan u ook naar andere locaties zoeken. De studie die u hebt gekozen verwijst door naar de originele pagina op clinicaltrials.gov. Bekijk deze pagina voor meer informatie. Reliable Cancer Therapies selecteert wekelijks beschikbare studies rond kanker.
Dit gedeelte van de website is alleen beschikbaar in het Engels.
It is still not clear whether a positive AGO-score just selects patients with less
aggressive biologic tumor behavior who as well would have had a positive outcome by
chemotherapy only, or , if it is a score selecting patients who really benefit from surgery.
Nevertheless, the AGO-score was confirmed to select patients with a less than 30% risk of
ending with residual tumor after surgery for recurrent disease. This could avoid including
patients into the present...
RATIONALE: Aspirin may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth. The use of aspirin may slow disease progression after surgery. It is not
yet known whether aspirin is more effective than a placebo in treating colorectal cancer
that has been completely removed by surgery.
PURPOSE: This randomized phase III trial is studying aspirin to see how well it works
compared with a placebo in treating patients with Dukes stage C...
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor
cells, either by killing the cells or by stopping them from dividing. Measuring blood levels
of tumor cells may help in learning how well chemotherapy works to kill metastatic breast
cancer cells and allow doctors to plan better treatment. When blood levels of tumor cells
are high while receiving chemotherapy, it is not yet known whether it is more effective to
change...
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and polyglutamate paclitaxel, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Paclitaxel and polyglutamate paclitaxel may also stop the
growth of ovarian epithelial or peritoneal cancer by blocking blood flow to the tumor.
Sometimes, after treatment, the tumor may not need additional treatment until it progresses.
In this case,...
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, carboplatin, and cisplatin, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Giving more than one drug (combination chemotherapy) and giving
them in different ways may kill more tumor cells. It is not yet known which combination
chemotherapy regimen is more effective in treating patients with ovarian epithelial cancer,
primary...
RATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different
ways to stop the growth of tumor cells, either by killing the cells or stopping them from
dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different
ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and
help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the
growth of tumor...
RATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different
ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and
help kill them or carry tumor-killing substances to them. It is not yet known whether
combination...
RATIONALE: Letrozole may prevent breast cancer in postmenopausal women with a BRCA1 or BRCA2
mutation.
PURPOSE: This randomized phase III trial is studying letrozole to see how well it works
compared with a placebo in preventing breast cancer in postmenopausal women with a BRCA1 or
BRCA2 mutation.
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor
cells, either by killing the cells or by stopping them from dividing. Giving more than one
drug (combination chemotherapy) and giving them after surgery may kill any tumor cells
remaining after surgery. It is not yet known whether docetaxel is more effective than
ixabepilone when given after surgery and combination chemotherapy in treating breast cancer.
PURPOSE: This...
RATIONALE: Estrogen can cause the growth of breast cancer cells. Letrozole may fight breast
cancer by lowering the amount of estrogen the body makes. It is not yet known which regimen
of letrozole is more effective in postmenopausal women who have received hormone therapy for
early-stage breast cancer.
PURPOSE: This randomized phase III trial is comparing two different regimens of letrozole in
preventing cancer in postmenopausal women who have received 4-6 years...
Wij voldoen aan de HONcode, die staat voor betrouwbare informatie over gezondheid:
Controleer hier.
Alle RCT-nieuws
- 1 of 7
- ››